Capital
R3i deploys and connects capital selectively where frontier technology, structural scarcity and credible institutional pathways converge.
Our investment work is informed by the same discipline as our transaction work: establish what is owned, what is proven, what remains uncertain and what must be true for value to compound.
01 · Investment lens
We look for assets that remain difficult to reproduce as software, models and information become increasingly abundant — proprietary science, intellectual property, validated data, industrial capability, regulated workflows, infrastructure or privileged access to market.
Technical narrative is not enough. We look for proof proportionate to the underlying claim and the capital required to advance it.
The technology must ultimately become legible to customers, regulators, strategic partners and future capital.
The structure, duration and expectations of capital must match the actual development pathway.
02 · Areas of attention
The same three domains govern transaction work and capital work. Sector boundaries matter less than whether the asset is scarce, defensible and capable of becoming institutionally executable.
AI · advanced compute · autonomy · defence
Energy · water · industrial infrastructure · critical materials
Health · life sciences
03 · For allocators
Institutional and strategic capital relationships are developed around specific opportunities, vehicles and mandates rather than generic access — including sovereign and pre-IPO secondaries in artificial intelligence, space, defence, critical infrastructure and biotechnology, where regulatory and ownership review shape who can participate.
Depending on structure, investors may engage with R3i around:
Vehicles are named, and their status stated, only in confidential offering documentation. Nothing on this page is an offer of securities, and no vehicle is represented as open for subscription.
04 · Conflicts
R3i may act as originator, adviser, investor or vehicle sponsor. The applicable role and any related-party interest are disclosed by mandate, before terms are agreed. Fee arrangements are disclosed in priority order, not layered silently, and Investment Committee members recuse themselves from decisions in which they hold a personal or related-party interest.
A risk-based AML/KYC policy applies across all entities and is a precondition of any commitment. R3i does not accept client transaction capital into its operating-company accounts.